Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent
© 2022 Wiley Periodicals LLC..
BACKGROUND: The major goal of routine follow-up in oropharyngeal squamous cell carcinoma (OPSCC) patients is the asymptomatic detection of new disease in order to improve survival. This study evaluated the effect of routine follow-up on overall survival (OS).
METHODS: A retrospective cohort of 307 consecutive OPSCC patients treated with curative intent between 2006 and 2012 was analyzed. The effectiveness of routine follow-up was studied by comparing treatment-intent and OS in patients with asymptomatically versus symptomatically detected new disease.
RESULTS: Three- and five-year risks of new disease were 29% (95% CI: 24-34) and 33% (95% CI: 27-39). Of the 81 patients with locoregional recurrence or second primary head and neck cancer, 8 (10%) were detected asymptomatically with no difference in OS with those detected with symptoms.
CONCLUSIONS: Asymptomatic detection of new disease during routine visits was not associated with improved OS. The focus of follow-up should be on providing psychosocial care and rehabilitation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Head & neck - 45(2023), 3 vom: 06. März, Seite 586-594 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Brands, Maria T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Head and neck cancer |
|---|
| Anmerkungen: |
Date Completed 03.02.2023 Date Revised 03.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/hed.27269 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350767483 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350767483 | ||
| 003 | DE-627 | ||
| 005 | 20231226045735.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hed.27269 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350767483 | ||
| 035 | |a (NLM)36565244 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Brands, Maria T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2023 | ||
| 500 | |a Date Revised 03.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: The major goal of routine follow-up in oropharyngeal squamous cell carcinoma (OPSCC) patients is the asymptomatic detection of new disease in order to improve survival. This study evaluated the effect of routine follow-up on overall survival (OS) | ||
| 520 | |a METHODS: A retrospective cohort of 307 consecutive OPSCC patients treated with curative intent between 2006 and 2012 was analyzed. The effectiveness of routine follow-up was studied by comparing treatment-intent and OS in patients with asymptomatically versus symptomatically detected new disease | ||
| 520 | |a RESULTS: Three- and five-year risks of new disease were 29% (95% CI: 24-34) and 33% (95% CI: 27-39). Of the 81 patients with locoregional recurrence or second primary head and neck cancer, 8 (10%) were detected asymptomatically with no difference in OS with those detected with symptoms | ||
| 520 | |a CONCLUSIONS: Asymptomatic detection of new disease during routine visits was not associated with improved OS. The focus of follow-up should be on providing psychosocial care and rehabilitation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a head and neck cancer | |
| 650 | 4 | |a oropharyngeal cancer | |
| 650 | 4 | |a recurrence | |
| 650 | 4 | |a routine surveillance | |
| 650 | 4 | |a second primary tumor | |
| 700 | 1 | |a Swinkels, Iris J |e verfasserin |4 aut | |
| 700 | 1 | |a Aarts, Anne M W M |e verfasserin |4 aut | |
| 700 | 1 | |a Verbeek, André L M |e verfasserin |4 aut | |
| 700 | 1 | |a Merkx, Matthias A W |e verfasserin |4 aut | |
| 700 | 1 | |a Marres, Henri A M |e verfasserin |4 aut | |
| 700 | 1 | |a Kaanders, Johannes H A M |e verfasserin |4 aut | |
| 700 | 1 | |a Melchers, Willem J G |e verfasserin |4 aut | |
| 700 | 1 | |a van Engen-van Grunsven, Ilse |e verfasserin |4 aut | |
| 700 | 1 | |a Takes, Robert P |e verfasserin |4 aut | |
| 700 | 1 | |a Geurts, Sandra M E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 45(2023), 3 vom: 06. März, Seite 586-594 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2023 |g number:3 |g day:06 |g month:03 |g pages:586-594 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/hed.27269 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2023 |e 3 |b 06 |c 03 |h 586-594 | ||